Slideshow
Author(s):
Parkinson disease articles published in 2018 reveal deeper dives into factors that include the impact of sleep and fatigue on symptoms.
FDA Grants Fast Track Designation to Promising Multiple System Atrophy Agent Amlenetug
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
Denali Plans to Submit BLA for Tividenofusp Alfa in Hunter Syndrome Following Positive Phase 1/2 Data
Neurology Unwrapped: 2024’s Most Intriguing Conversations
NeurologyLive® Friday 5 — February 7, 2024
Insights on the Newly Approved Subcutaneous Infusion Therapy for Parkinson Disease